DE3751409T2 - Monoklonale Antikörper gegen Interferon-induziertes humanes Protein in gereignigter Form, und diese Antikörper enthaltende Testsätze. - Google Patents

Monoklonale Antikörper gegen Interferon-induziertes humanes Protein in gereignigter Form, und diese Antikörper enthaltende Testsätze.

Info

Publication number
DE3751409T2
DE3751409T2 DE3751409T DE3751409T DE3751409T2 DE 3751409 T2 DE3751409 T2 DE 3751409T2 DE 3751409 T DE3751409 T DE 3751409T DE 3751409 T DE3751409 T DE 3751409T DE 3751409 T2 DE3751409 T2 DE 3751409T2
Authority
DE
Germany
Prior art keywords
proteins
monoclonal antibodies
test kits
kits containing
suitable form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3751409T
Other languages
English (en)
Other versions
DE3751409D1 (de
Inventor
Michel Andre Horisberger
Heinz-Kurt Hochkeppel
Jean Content
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868609162A external-priority patent/GB8609162D0/en
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE3751409D1 publication Critical patent/DE3751409D1/de
Application granted granted Critical
Publication of DE3751409T2 publication Critical patent/DE3751409T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4718—Cytokine-induced proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
DE3751409T 1986-04-15 1987-04-09 Monoklonale Antikörper gegen Interferon-induziertes humanes Protein in gereignigter Form, und diese Antikörper enthaltende Testsätze. Expired - Lifetime DE3751409T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868609162A GB8609162D0 (en) 1986-04-15 1986-04-15 Protein
GB868625381A GB8625381D0 (en) 1986-04-15 1986-10-23 Interferon-induced human protein

Publications (2)

Publication Number Publication Date
DE3751409D1 DE3751409D1 (de) 1995-08-24
DE3751409T2 true DE3751409T2 (de) 1996-01-25

Family

ID=26290626

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3751409T Expired - Lifetime DE3751409T2 (de) 1986-04-15 1987-04-09 Monoklonale Antikörper gegen Interferon-induziertes humanes Protein in gereignigter Form, und diese Antikörper enthaltende Testsätze.

Country Status (10)

Country Link
EP (1) EP0242329B1 (de)
JP (2) JPH0822880B2 (de)
AT (1) ATE125304T1 (de)
AU (1) AU608216B2 (de)
CA (1) CA1340289C (de)
DE (1) DE3751409T2 (de)
DK (1) DK172677B1 (de)
ES (1) ES2074420T3 (de)
IE (1) IE67564B1 (de)
PT (1) PT84670B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0331635A3 (de) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Zubereitungen zur Behandlung von Blasenkrebs.
WO1994002606A1 (en) * 1992-07-20 1994-02-03 The Government Of The United States Of America, Asrepresented By The Secretary Of The Department Of Health And Human Services Inhibition of retroviral expression by interferon-induced cellular genes and proteins
US5792626A (en) * 1996-09-18 1998-08-11 Incyte Pharmaceuticals, Inc. Human interferon-inducible protein
CA2397254A1 (en) * 2000-02-09 2001-08-16 Pharma Pacific Pty Ltd. Interferon-alpha induced genes
CA2397369A1 (en) * 2000-02-11 2001-08-16 Jean-Francois Meritet Interferon-alpha induced genes
JP2004530420A (ja) * 2000-06-29 2004-10-07 ファーマ パシフィック プロプライエタリー リミテッド インターフェロン−α誘導性遺伝子
CA2421234A1 (en) * 2000-09-14 2002-03-21 Pharma Pacific Pty. Ltd. Interferon-alpha induced gene
GB0030184D0 (en) * 2000-12-11 2001-01-24 Pharma Pacific Pty Ltd Interferon alpha induced gene
WO2002068470A2 (en) * 2001-02-26 2002-09-06 Pharma Pacific Pty Ltd Interferon-alpha induced gene

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU538665B2 (en) 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
NO164037C (no) 1980-01-08 1990-08-22 Biogen Inc Fremgangsmaate ved fremstilling av et polypeptid av interferon alfa (ifnalfa)-type.
DE3026832A1 (de) 1980-07-16 1982-02-11 Klöckner-Humboldt-Deutz AG, 5000 Köln Zerstaeuberduese fuer kontinuierliche brennstoffeinspritzung
EP0072541A3 (de) 1981-08-14 1984-04-18 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Menschliche Leukozyten-Interferone, Verfahren zu deren Mikrobiologischer Herstellung, Zwischenprodukte und diese enthaltende Zusammensetzungen
GB2108510B (en) 1981-10-03 1984-12-12 Ciba Geigy Ag Dnas, recombinant dnas, hosts containing them, polypeptides and processes for the production thereof
WO1987000864A1 (en) * 1985-07-31 1987-02-12 Peter Staeheli Insertion into animals of genes coding for interferon-induced proteins

Also Published As

Publication number Publication date
IE67564B1 (en) 1996-04-17
JPH0822880B2 (ja) 1996-03-06
ATE125304T1 (de) 1995-08-15
EP0242329A2 (de) 1987-10-21
DK172677B1 (da) 1999-05-17
JPS62270599A (ja) 1987-11-24
JPH07236497A (ja) 1995-09-12
CA1340289C (en) 1998-12-29
IE870966L (en) 1987-10-15
AU7151087A (en) 1987-10-22
AU608216B2 (en) 1991-03-28
DE3751409D1 (de) 1995-08-24
DK193187D0 (da) 1987-04-14
PT84670A (en) 1987-05-01
PT84670B (pt) 1989-11-30
EP0242329A3 (en) 1989-09-13
ES2074420T3 (es) 1995-09-16
JP2572956B2 (ja) 1997-01-16
EP0242329B1 (de) 1995-07-19
DK193187A (da) 1987-10-16

Similar Documents

Publication Publication Date Title
Van Damme et al. Separation and comparison of two monokines with lymphocyte-activating factor activity: IL-1 beta and hybridoma growth factor (HGF). Identification of leukocyte-derived HGF as IL-6.
Kirchner et al. A whole-blood technique for testing production of human interferon by leukocytes
Van Damme et al. The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor.
Bryan Vinblastine and microtubules: II. Characterization of two protein subunits from the isolated crystals
US4485017A (en) Isolation of human interferon by immunosorbent and high performance liquid chromatography
Curry et al. A sensitive immunochemical assay for biologically active MuIFN-γ
Sheehan et al. Generation and characterization of monoclonal antibodies specific for the human IFN-gamma receptor.
Caruso et al. Natural antibodies to IFN-gamma in man and their increase during viral infection.
Thurman et al. MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody.
NO176570C (no) Proteinmateriale, inhibin, fremgangsmåte for renfremstilling av dette, antistoff mot inhibin, ikke-terapeutiske blandinger inneholdende inhibin/antistoff samt anvendelse for diagnostiske og analytiske formål
BG60256B1 (bg) Рекомбинантен метод за получаване на лимфотоксин
Novick et al. Monoclonal antibodies to human alpha-interferon and their use for affinity chromatography.
Schooley et al. Immunochemical studies of human urinary erythropoietin.
von Wussow et al. MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus
Orchansky et al. The interferon-gamma receptor in human monocytes is different from the one in nonhematopoietic cells.
Chess et al. Leukocyte inhibitory factor (LIF): production by purified human T and B lymphocytes
Sarfati et al. Purification and partial biochemical characterization of IgE-binding factors secreted by a human B lymphoblastoid cell line.
Moroni Structural proteins of Rauscher leukemia virus and Harvey sarcoma virus
Van Damme et al. Inferferon induced in human leukocytes by concanavalin A: isolation and characterization of γ‐and β‐type components
DE3751409T2 (de) Monoklonale Antikörper gegen Interferon-induziertes humanes Protein in gereignigter Form, und diese Antikörper enthaltende Testsätze.
Mattes et al. Antisera to frog immunoglobulins cross-react with a periodate-sensitive cell surface determinant
Ralph et al. Human B cell-inducing factor (s) for production of IgM, IgG and IgA: independence from IL 2.
Deng et al. Molecular characteristics of SS-B/La and SS-A/Ro cellular antigens.
Altevogt et al. Biochemical comparison of HLA‐DR molecules derived from autologous human T and B lymphoblasts
Al-Masri et al. Intracellular staining of Mx proteins in cells from peripheral blood, bone marrow and skin.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS AG, BASEL, CH

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN